FEMSelect
PrivateLast Round
Series B
Extension
May 13, 2025
Total Funding Raised
$14.3M
Company Overview
FEMSelect is a medical technology company that develops minimally invasive surgical systems for the treatment of pelvic organ prolapse.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
pelvic organ prolapsesurgical meshminimally invasive surgeryurogynecologypelvic floor reconstructionmedical devicesurgical systemwomen's healthPOP repairmesh-free surgerysurgical kitspelvic floor disorders
Historical Pricing
Historical view of private secondary pricing and transaction trends.
FEMSelect Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
FEMSelect Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | May 13, 2025 | ||||
| Series B | Oct 19, 2022 | ||||
| Series A | Jan 24, 2018 | ||||
| Seed | Dec 1, 2012 |
FEMSelect Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Nordwand Capital | Series B Extension |
| TransPacific Venture Partners | Series B |
| Robin Hood Ventures | Series B Extension, Series B |
| Keiretsu Capital | Series B |
| MEDA Angels | Series B |
| Keiretsu Forum Mid-Atlantic | Series B |
| Triventures | Series B Extension, Series B, Series A |
FEMSelect Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about FEMSelect's valuation, stock price, and market status.
Firmographic Details
HeadquartersNew York City, New York
Employee Range13
Year Founded2012
Last FundingMay 13, 2025